Studies have shown that AS patients with elevated blood levels of MMP-3 have a higher likelihood of developing subclinical atherosclerosis, thereby increasing the risk of severe cardiovascular events such as myocardial infarction. This evidence concerns the gene MMP3 and atherosclerosis.